Covetrus Releases Signature Enhancements to its Industry-Leading AVImark Practice Management Software for Veterinary Practices

Enhancements Offer New Integration Capabilities While Providing Seamless User Experience and Workflow

PORTLAND, Maine–(BUSINESS WIRE)–Jun. 17, 2019– Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, announced today the release of signature product enhancements to its AVImark practice management software, including new functionality that streamlines common veterinary practice administrative tasks and drives greater coordination between the medical record and Covetrus’ prescription management technology.

These AVImark enhancements represent one of the many planned innovation investments across our technology assets that are scheduled to go-live in 2019 as Covetrus looks to improve workflow, create time savings for caregivers and staff, simplify practice operations and enhance clinical and financial health for our growing customer base.

“The growing complexity of managing a small business in an evolving veterinary landscape is increasing the burden on the veterinarian and their team of professionals,” said Chris Dollar, senior vice president and president, Global Software Services. “Our increased investment in practice management software for 2019 demonstrates our commitment to our customers as we look to not only deliver a better user-experience but to also launch next-generation functionality and workflow improvements to help these practices deliver quality patient care.”

Some of the new AVImark enhancements and features include:

Medical record quick copy forward: This allows practitioners to quickly copy and add new notes on a patient’s condition, significantly reducing the amount of time spent on medical record note taking.
Prescription management coordination: Prescriptions filled by the Covetrus prescription management technology flow directly to the patient’s medical record, bringing a complete view of a patient’s medication history inside AVImark. By pairing AVImark with the Covetrus prescription management technology, practices can bring compliance to a whole new level.
Quick indicators: New indicators help with quick determinations of statuses to simplify AVImark customers’ work. Wellness plan indicators allow staff members to see patients on wellness plans. Estimates that have been approved now have a clear locked indicator from the main screen to ensure staff members know which estimate has currently been accepted by the pet owner. Practitioners can save time by getting a list of their open medical records through an information search.

These AVImark upgrades come on the heels of new integrations and innovations launched by other Covetrus practice management solutions in the second quarter of 2019, including Covetrus prescription and inventory management integration for eVetPractice, multiple performance improvements that enhance speed to launch for ImproMed software customers, and significant new features for RxWorks internationally.

Covetrus Global Software Services will showcase these and other future innovations at VetSummit 2019: October 9-11 in Indianapolis, Indiana.

About Covetrus

Covetrus is a global animal-health technology and services company dedicated to empowering veterinary practice partners to drive improved health and financial outcomes. We’re bringing together products, services, and technology into a single platform that connects our customers to the solutions and insights they need to work best. Our passion for the well-being of animals and those who care for them drives us to advance the world of veterinary medicine. Covetrus is headquartered in Portland, Maine, with more than 5,000 employees, serving over 100,000 customers around the globe. For more information about Covetrus visit https://www.covetrus.com.

Forward-Looking Statements

This press release contains certain statements that are forward-looking within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and that involve risks and uncertainties, including statements about our future financial and operating results, plans, objectives, expenses, expectations, intentions, trends in our business, our liquidity, product development and improvements, and other matters. We may, in some cases use terms such as “predicts,” “believes,” “potential,” “continue,” “anticipates,” “estimates,” “expects,” “plans,” “intends,” “may,” “could,” “might,” “likely,” “will,” “should” or other words that convey uncertainty of the future events or outcomes to identify these forward-looking statements. Such statements are subject to numerous risks and uncertainties, including but not limited to, risks associated with the ability to successfully integrate operations and employees; the ability to realize anticipated benefits and synergies of the transaction that created Covetrus; the potential impact of the consummation of the transaction on relationships, including with employees, customers and competitors; the ability to retain key personnel; the ability to achieve performance targets; changes in financial markets, interest rates and foreign currency exchange rates, and those additional risks and factors discussed in our Annual Report on Form 10-K filed on March 29, 2019 and Quarterly Report on Form 10-Q filed for the quarter ended March 31, 2019, including those discussed under the heading “Risk Factors.” Our forward-looking statements are based on current beliefs and expectations of our management team and, except as required by law, we undertake no obligations to make any revisions to the forward-looking statements contained in this release or to update them to reflect events or circumstances occurring after the date of this release, whether as a result of new information, future developments or otherwise. Investors are cautioned not to place undue reliance on these forward-looking statements.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190617005247/en/

Source: Covetrus

Nicholas Jansen
Investor Relations
nicholas.jansen@covetrus.com
(207) 550-8106

Kiní Schoop
Public Relations
kini.schoop@covetrus.com
(207) 550-8018